About a month after four drugmakers reported shortages of their Adderall generics, the list has grown from 20 to 28 out-of-stock drugs from six pharmaceutical companies. 

The FDA publishes less than a third of research for drug safety updates, and Yale researchers said the "spontaneous reporting" highlights the need for greater transparency. 

Cincinnati-based St. Vincent de Paul Charitable Pharmacy is on track to hit $100 million in free prescriptions by the end of October, ABC affiliate WCPO reported Oct. 5.

The White House's vision of revamping Operation Warp Speed, a Trump-era program that was geared toward accelerating the approval process for COVID-19 vaccines and therapies, has failed to pick up, Politico reported Oct. 5. 

BlueBird Bio's two drugs for rare diseases that each cost about $3 million — the most expensive drugs on the market — are fairly priced, the chief operating officer at a rival drugmaker told Bloomberg in an Oct. 5 report. 

Hugh Chancy was appointed president of the National Community Pharmacists Association for 2022-23.

Biotech company Ocugen signed an exclusive agreement with Washington University in St. Louis to develop, manufacture and sell technology developed at the school. 

The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.

After Amylyx Pharmaceuticals announced the price of its recently approved amyotrophic lateral sclerosis treatment, the drugmaker's co-CEOs told Politico why it costs $158,000 for one patient's annual supply. 

More than 40 organizations asked the FDA to amend the label on mifepristone, a drug used in medication abortion, to add miscarriage management to its drug approval label. 

Avita, a Plano, Texas-based pharmacy services provider, acquired AbsoluteCare Atlanta's medical center and pharmacy Oct. 5. 

The HHS allotted $55 million to fund Vir Biotechnology's influenza drug and up to $1 billion to prevent future infectious disease threats. 

Following a federal judge's ruling that instructed HHS to immediately pay for 340B hospitals' drug costs, the agency will increase payment rates in two weeks after the HHS shrank reimbursements for years, according to the American Hospital Association. 

During its annual convention in Kansas City, Mo., the National Community Pharmacists Association recently awarded eight pharmacists, pharmacy owners and educators for their efforts in the industry:

Alexion Pharmaceuticals, a subsidiary of the drugmaker AstraZeneca, plans to acquire LogicBio Therapeutics, a gene therapy company. 

A study of nearly 150,000 people found that taking antidepressants during pregnancy does not increase the risk of neurodevelopmental disorders, such as autism and attention-deficit/hyperactivity disorder, in children. 

New York City-based drugmaker Pfizer recently acquired a migraine company for $11.6 billion and released positive results from a phase 3 trial for its prostate cancer drug. 

For the second year in a row, Fortune has declared CVS Health CEO and president Karen Lynch the No. 1 most powerful woman in business. 

Bluebird Bio sells two of the most expensive drugs on the market, both priced at about $3 million per patient, but they may not be enough to keep the business afloat, The Wall Street Journal reported Oct. 3. 

Walgreens' specialty and home delivery pharmacy business, AllianceRx, gained reaccreditation Oct. 4 for its specialty services.